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ABSTRACT We present immunophysical modeling for VCP, SPICE, and three mutants using MD simulations and Poisson-
Boltzmann-type electrostatic calculations. VCP and SPICE are homologous viral proteins that control the complement system
by imitating, structurally and functionally, natural regulators of complement activation. VCP and SPICE consist of four CCP
modules connected with short ﬂexible loops. MD simulations demonstrate that the rather complex modules of VCP/SPICE and
their mutants exhibit a high degree of intermodular spatial mobility, which is affected by surface mutations. Electrostatic
calculations using snapshots from the MD trajectories demonstrate variable spatial distribution of the electrostatic potentials,
which suggests dynamic binding properties. We use covariance analysis to identify correlated modular oscillations. We also use
electrostatic similarity indices to cluster proteins with common electrostatic properties. Our results are compared with
experimental data to form correlations between the overall positive electrostatic potential of VCP/SPICE with binding and
activity. We show how these correlations can be used to predict binding and activity properties. This work is expected to be
useful for understanding the function of native CCP-containing regulators of complement activation and receptors and for the
design of antiviral therapeutics and complement inhibitors.
INTRODUCTION
The complement system is an evolutionarily ancient form of
innate immunity and a bridge between innate and adaptive
immunities (1–5). The complement system has mechanisms
in place for recognition, binding, and elimination of foreign
pathogens, among them viruses and virally infected cells. On
the other hand, viruses have evolved mechanisms for evasion
of the complement system and immune system in general (6–
8). The variola and vaccinia viruses, both members of the
genusOrthopoxvirus, are capable of inhibiting and regulating
the complement system by mimicking the function of natural
RCAs (9–12). The variola virus is the causative agent of
smallpox disease, which was eradicated using the less potent
vaccinia virus as an inoculation agent (11). Little is known of
the mechanisms of function of the orthopoxviruses, and a
renewed need to understand and inhibit their function has
been generated with recent biosafety concerns (13,14).
The vaccinia virus encodes the VCP and the variola virus
encodes the SPICE protein, which are secreted by infected
cells (9–12). VCP and SPICE inhibit the activation of the
complement system by acting on complement components
C3b and C4b and disallowing their function. VCP acts as a
cofactor of Factor I in the enzymatic cleavage and inactiva-
tion of C3b and C4b and accelerates the decay of C3 con-
vertase complexes (which contain C3b or C4b) (6–12).
SPICE is also known to act as a cofactor of Factor I in the
enzymatic cleavage and inactivation of C3b and C4b
(10,11). C3b and C4b are the opsonins that coat the surfaces
of infecting viruses for recognition and elimination by
phagocytes. C3b and C4b are also building blocks of the so-
called C3 and C5 convertase enzymes, which are responsible
for the cleavage of C3 to C3a and C3b and C5 to C5a and
C5b. C3a and C5a are promoters of inﬂammatory response
and C5b is a building block of MAC, which is capable of
lysing the membranes of cell-free viruses. The complement
system is ﬁnely regulated by RCAs, such as C4BP, CR1,
MCP, DAF, and Factor H, and interacts with CRs such as
CR1 (also an RCA) and CR2 (not an RCA). The regulated
complement components by RCAs are C3b and C4b and
their variants and the convertases they form. A structural over-
view of the complement activation and regulation pathways,
CRs, and selected inhibitors has been presented (15). Also, a
structural classiﬁcation of RCAs has been presented (16).
VCP, SPICE, most RCAs, and CRs have similar sequence
and structural characteristics. They are modular proteins
containing several CCP modules, also known as SCR
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modules, connected by ﬂexible loops to form long chains
(16). VCP and SPICE are formed by four CCPmodules, which
are arranged in a nearly linear chain according to the x-ray
diffraction structures of the four-module protein (17,18) or
the NMR structures of two-module fragments (19,20). The
structural resemblance of VCP and SPICE to RCAs is respon-
sible for the complement system evasion by their respected
vaccinia and variola viruses. The mechanism of binding of
VCP and SPICE to their targets, C3b and C4b, and resulting
inhibition of complement activation is largely unknown. This
makes necessary structural and computational studies at atomic
level to understand the physicochemical properties of VCP/
SPICE responsible for binding and inhibition.
VCP and SPICE differ by only 11 amino acids, but their
inhibitory activities differ by up to 1000-fold, with SPICE
being more active. A recent study has shown that SPICE is
75-fold and 1000-fold more active than VCP in inhibiting the
classical and the alternative pathways, respectively, of comple-
ment activation (21). An earlier study had shown that SPICE
was 100-fold and 6-fold more potent than VCP in inacti-
vating C3b and C4b, respectively, in the presence of Factor I
(22). There are subtleties in the activities of VCP and SPICE.
VCP is a better inhibitor of the classical pathway, whereas
SPICE is a better inhibitor of the alternative pathway of
complement activation (21). Both VCP and SPICE exhibit
species speciﬁcity (22). The study by Sfyroera et al. (21) has
pointed out the importance of the modulation of the elec-
trostatic potential of VCP, SPICE, and several mutants in the
binding to C3b and in inhibiting complement activation by
using a static crystallographic structure ofVCP and amodeled
structure of SPICE. Here, we present immunophysical mod-
eling of VCP and SPICE. We have performed a detailed
analysis of the physicochemical properties ofVCP andSPICE
that are responsible in modulating their electrostatic poten-
tials, including their dynamics.
Our modeling involves MD simulations and electrostatic
calculations. We have used MD to explore the conformational
space of VCP and SPICE. We have examined the ﬂexibility,
mobility, and correlated motions of the four modules of VCP
and SPICE by analyzing the MD trajectories. Furthermore, we
have explored the ionization properties and the spatial
distribution of charge and electrostatic potentials using the
MD data and electrostatic calculations based on the solution of
the Poisson-Boltzmann equation. We use our data to explain
the differences in the activities of the two proteins. In addition,
we use our data to predict the minimum number of mutations
that are sufﬁcient to increase or reduce the activities ofVCPand
SPICE. Most of our results are compared to experimental
mutagenesis, binding, and activity data. We discuss our pro-
posed binding model in view of earlier studies involving the
interaction of C3d with CR2 (23) because of a similar pre-
dominant role of electrostatics in binding. Also, we discuss
similarities between the structural and functional character-
istics of VCP/SPICEwith CR1,MCP, andDAF because VCP
has CR1-, MCP-, and DAF-like activities (6).
This work contributes to our current understanding of the
function of VCP and SPICE by providing mechanistic
modeling at atomic and biomolecular levels. We expect that
our models and predictions will be useful in the renewed
interest in the design of antiviral therapeutics (14). We also
expect that this work will contribute to our understanding of
the function of regulators of complement activation and
receptors, for which CCPs are the basic building blocks. This
knowledge will aid in the design of complement inhibitors
useful against several pathological situations where unreg-
ulated complement activation is observed. Methodologi-
cally, this work shows the power of computational physical
methods for immunology research (24).
METHODS
Structural modeling
Our computational modeling is based on the crystallographic structure of
VCP with PDB (25) Code 1G40 (17). Chain A of 1G40 was extracted from
the dimeric VCP crystal structure and was used for structural homologymod-
eling of SPICE, VCP2m, VCP3m, and VCP4m. We used the program Swiss
PDB Viewer (26) to incorporate mutations in the structure 1G40 of VCP.
Energy minimization was performed to optimize the conformation of the
mutating amino acids. The sequences of the modeled structures are given in
Fig. 1. There are 2–11 mutations in the modeled structures compared to
VCP, 2 in VCP2m, 3 in VCP3m, 4 in VCP4m, and 11 in SPICE. The crystal
structure of VCP and the modeled structures of SPICE, VCP2m, VCP3m,
and VCP4m were used in the MD simulations (see below).
MD simulations
The program CHARMM (27) version 31b1 was used to perform MD
simulations with the EEF1 implicit solvent model (28). EEF1 adds solvation-
free energy to the vacuum-free energy function of a biomolecule. The
solvation-free energy contains contributions from two effects, the exclusion
of solvent from the space occupied by solute groups (self-energy of charges)
and modiﬁcations of the solvent in the nonsolute remaining space (dielectric
screening of interactions between all pairs of solute charges). The authors of
EEF1 point out that this solvation model is useful to discriminate native
conformations from misfolded decoys (29,30). In this work, values of all the
parameters of the EEF1 model were set to their default values as imple-
mented in the CHARMM 31b1 program with an electrostatic and van der
Waals cutoff of 9 A˚ and a switching function between 7 and 9 A˚. EEF1 uses
the CHARMM 19 polar hydrogen energy function. The SHAKE algorithm
(31) was used to ﬁx the length of covalent bonds of hydrogen atoms. The
time step was set to 1 fs. We have enforced disulﬁde bridges as shown in Fig.
1, using patches in CHARMM. All structures were ﬁrst energy minimized
for 300 steps with the ABNR method. Then, the systems were subjected to
5 ps of constant volumeMD simulation, during which the temperature of the
system was raised from 0 K to 300 K with velocity rescaled every 0.1 ps. At
300 K, 30 ps equilibration phase was initiated, with velocity rescaled every
0.1 ps during the ﬁrst 10 ps. In the later stage of the equilibration, velocity
was rescaled only if the temperature of the system deviated more than 5 K
from 300 K. At the end of the equilibration, energy and temperature were
stable, and no velocity rescaling was necessary for the last 10 ps. After the
equilibration, 10 ns of NVT MD at 300 K was run with a Nose-Hoover
thermostat (32,33). Coordinate sets were sampled every 10 ps to generate
1000 snapshots of structures during the MD trajectory. Energy minimization
was performed at the end of each MD snapshot.
CHARMM utilities and homemade programs were used to analyze the
MD trajectories. The RMSD time series, averaged over the N, Ca, and C
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backbone heavy atoms, were calculated relative to the minimized crystal
structure. The relative intermodular position of two CCP domains was char-
acterized by tilt, twist, and skew angles (16,19,20,34–37). The boundaries of
each single CCP domain were deﬁned by the ﬁrst and fourth disulﬁde-
bonded cysteines (Fig. 1). To deﬁne the coordinate system of each domain,
we set the center of its mass as the origin point of the domain, and the z axis
was aligned with the principal inertia tensor of the domain pointing toward
the C-terminus. The direction of the x axis was deﬁned with reference to Ca
atom of the consensus conserved Trp (see Fig. 1 for Trp location). The y axis
was determined by the right-hand rule. To calculate the angles between the
neighboring domains, centers of masses of the neighboring domains were
superimposed without changing any of the angles. A homemade FORTRAN
program was used to calculate the tilt, skew, and twist angles, using the
mathematical formulas described in Lehtinen et al. (35). Note that we have
calculated the principal inertia tensor using CHARMM with only polar
hydrogen atoms present. Also, the ﬁrst (free) cysteine, the intermodular
loops, and the two-amino acid C-terminal loop (Fig. 1) are not considered in
our calculation of principal inertia tensors. These selections may be different
from other calculations in the literature (16,20,34–36). SASA was calculated
using CHARMM with a probe radius 1.4 A˚. The differences in SASA
(DSASA) were calculated according to DSASA ¼ Si[SASA(CCPi)] 
SASA[Si(CCPi)], where i refers to module number. In the SASA calcu-
lations the length of individual CCP modules is deﬁned in the rows of Fig. 1,
including loops outside the disulﬁde bonded cysteines.
Covariance analysis of the intermodular mobility was performed using the
10-ns MD trajectories of VCP, SPICE, VCP2m, VCP3m, and VCP4m. Equal-
time covariances were calculated for the displacement vectors Dri and Drj of
modules i and j according to cði; jÞ ¼ ÆDri  Drjæ, where the brackets denote
ensemble average (38). The displacement vectors were deﬁned from the
protein center ofmass to the center ofmass of eachCCPmodule. The center of
mass was calculated using Ca-atoms, and the constituent amino acids of each
CCPmodule are shown in Fig. 1. The ensemble average is estimated from the
MD trajectory according to cði; jÞ ¼ ð1=NÞ+N
n¼1 DriðtnÞDrjðtnÞ, where
DriðtnÞ is the displacement of module i at time tn with respect to its average
position during the trajectory and N¼ 1000 is our number of MD snapshots.
The cross correlation between modules i and j were calculated according
to Cði; jÞ ¼ ðcði; jÞÞ=ð ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃcði; iÞcðj; jÞp Þ ¼ ðÆDri  DrjæÞ=ð
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ÆDr2i æÆDr2j æ
q
Þ, where
C(i,j) ¼ 1 for completely correlated motions, C(i,j) ¼ 1 for completely
anticorrelated motions, and C(i,j)¼ 0 for uncorrelated motions. The quantity
C(i,j) describes correlatedmodular oscillationswhen the angles formed by the
motional directions of the twomodules are close to 0 or 180. In other words,
C(i,j) depicts if the two modules move together in the same direction or in
opposite directions but not more complex twist or orthogonal motions (39).
Electrostatic calculations
The calculation of apparent pKa values of ionizable sites in the interior
of proteins is possible if model and intrinsic pKa values and the matrix of
ionizable site-site interactions of all ionizable sites are available. The model
pKa is an experimental quantity that corresponds to the ionization of a free
ionizable site (amino acid) in solution. The intrinsic pKa is a hypothetical
quantity that corresponds to the pKa of a speciﬁc ionizable site in the interior
of the proteins in the absence of interaction with other ionizable sites, which
are considered neutral. The apparent pKa corresponds to the interaction of an
ionizable site with all other ionizable sites in their ionized state. The method
of Antosiewicz et al. (40,41), implemented within the program UHBD (42),
was used for the calculation of intrinsic pKa values for the ﬁnal (10 ns) min-
imized MD structures. Apparent pKa values were calculated using the clus-
tering method (43), implemented within the program HYBRID (43). The
ﬁnite difference Poisson-Boltzmann solver of UHBD was used to calculate
the electrostatic potential with continuum solvent representation. Dielectric
coefﬁcients of 78.4 and 20 were used for the solvent and protein interior, respec-
tively. The temperature was set to 298 K and the ionic strength was set to 150
mM salt concentration. The parameter set of charges and van der Waals radii
PARSE (44) was used. The solvent probe that deﬁnes the molecular surface
had a radius of 1.4 A˚. Dielectric smoothing at the protein-solvent interface
(45,46) was used with an ion exclusion layer deﬁned by a probe of 2.0 A˚
radius. Finite difference focusing methods (47,48) were used in the cal-
culations, with focusing grids of 4.0, 2.5, 1.25, 0.5, and 0.25 A˚. The ionic
strength dependence of the electrostatic potentials is calculated in the
Boltzmann part of the Poisson-Boltzmann equation in the form of a variable
that is a function of the Debye length (49).
The addition of hydrogen atoms for the pKa calculations was accom-
plished using the program WHAT IF version 99 (50,51). The program
WHAT IF was also used to perform a global hydrogen-bonding network
optimization, which corrected for the side-chain orientation of nonoptimal
His, Asn, and Gln amino acids and established the initial hydrogen position
at the Ne2 or Nd1 atom of His. Finally, WHAT IF was used to establish the
neutral state of Asp, Glu, and C-terminus amino acids by adding a hydrogen
atom at the Od2, Oe2, and OXT atoms, respectively. Changes from the neutral
to the charged state of ionizable amino acids were made by adding a
FIGURE 1 Sequence alignment of VCP, SPICE,
VCP2m, VCP3m, and VCP4m. Only mutated amino
acids are shown for SPICE, VCP2m, VCP3m, and
VCP4m, the remaining amino acids being the same as
in VCP. The ﬁgure also displays the alignment of the
four CCP modules with respect to each other. In each
CCP module, there are four conserved cysteines form-
ing two disulﬁde bridges (marked in ﬁgure) and a
single conserved tryptophan. The end amino acids of
each CCP module are the ﬁrst and fourth of the con-
served cysteines.
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61 charge to each ionizable site, depending on their charge. Positive unit
charges were added at the backbone amide N atom of the N-terminus, Nz of
Lys, and Cz of Arg amino acids. The WHAT IF hydrogen-bonding opti-
mization calculation showed that the initial hydrogen atom in all His amino
acids was located at the Nd1 position, thus the 11 charge was added at Ne2.
Negative unit charges were added at the backbone carboxyl C atom of the
C-terminus, Cg of Asp, Cd of Glu, Oh of Tyr, and Sg of free Cys amino
acids. The experimental model pKa values were 12.0 for Arg, 10.4 for Lys,
9.6 for Tyr, 8.3 for Cys, 6.3 for His, 4.4 for Glu, 4.0 for Asp, 7.5 for the
N-terminus, and 3.8 for the C-terminus.
Electrostatic potential calculations for the isopotential contour plots were
performed using the program GRASP (49,52), with the PARSE parameter
set (44), dielectric coefﬁcients of 4 and 78.5 for the protein and solvent,
respectively, solvent radius of 1.4 A˚, in the absence of salt, and in the pres-
ence of 150 mM salt. In the structures used for the GRASP calculations,
hydrogens were added and optimized for their hydrogen-bonding network
using WHAT IF (50,51).
ESIs were calculated using the program PIPSA (53,54) and analyzed
according to the clustering method described in De Rienzo et al. (54). First,
the APBS program (55) with the PARSE parameter set (44) was used to
compute the molecular electrostatic potentials of the proteins at ionic
strengths corresponding to 0 mM and 150 mM and a temperature of 298 K.
A grid dimension of 161 3 161 3 161 A˚3 with a 0.8 A˚ grid spacing was
used, centered on the global center of mass of the superimposed structures.
The dielectric coefﬁcients of the protein and the solvent were set to 2 and
78.5. The dielectric boundary was determined from the van der Waals
surface of the protein, and dielectric boundary smoothing was implemented.
Second, pairwise ESIs were calculated on the intersection of the electrostatic
potentials of the proteins using the whole grid potentials from the APBS
calculation. Third, the comparison of the ESIs was carried out by
constructing a distance matrix, which was used to cluster proteins of similar
electrostatic potentials by projecting the distance matrix onto the Euclidian
space, as described in De Rienzo et al. (54). Clustering of proteins with
similar ESIs was visualized and plotted using the program MAGE (56).
Molecular graphics
Molecular graphics have been created with the programs MOLMOL (57),
Swiss PDB viewer (26), and GRASP (49,52). Nomenclature compatibility
between PDB, WHAT IF, UHBD, MOLMOL, and GRASP and preparation
for UHBD runs was attained using a series of homemade PERL scripts.
RESULTS
Previous studies on the interaction of RCAs or CRs with
complement components have shown the importance of the
overall electrostatic potential and complementary surface
charge for recognition and association. These studies involve
the characterization of the CR1-C3b (36), CR1-C4b (36,58),
CR2-C3d (23,59–61), MCP-C3b/C4b (62), DAF-Factor B
(63), and VCP-heparin (17,18,64) interactions, and the
function of viral proteins VCP/SPICE (21,22), and Kaposi’s
sarcoma-associated herpesvirus complement control protein,
KCP (also known as Kaposi’s sarcoma-associated herpesvi-
rus inhibitor of complement activation, KAPOSICA) (10,65).
These studies prompted us to explore the dynamic and
electrostatic properties of VCP and SPICE, with the goal to
explain their difference in binding to C3b and the measured
up to 1000-fold higher complement inhibitory activity for
SPICE (21,22). We have also extended our studies to include
a two-amino acid mutant of VCP (called VCP2m) with
higher complement inhibitory activity than VCP and nearly
equal activity as SPICE (21). Based on our modeling for
VCP, SPICE, and VCP2m, we predict that a four-amino acid
mutant of VCP (called VCP4m) should have higher inhib-
itory activity than SPICE and that a three-amino acid mutant
(called VCP3m) should have lower inhibitory activity than
VCP. Fig. 1 shows the sequence alignment of VCP, SPICE,
and their two-, three-, and four-amino acid mutated analogs
with predicted enhanced or reduced complement inhibitory
activities compared to VCP. Fig. 1 also depicts the sequence
alignment among the four homologous CCP modules per
protein. The rationale for the design of the mutants, based on
their electrostatic properties, is described below.
We have performed MD simulations for VCP to eliminate
unfavorable crystal packing effects, to reach an energetically
global minimum for its structure, and to determine its confor-
mational ﬂexibility and mobility and correlated modular
motions. We deﬁne here ﬂexibility as the backbone and side-
chain dynamics within each CCP module and mobility as the
intermodular dynamics. We have also performed MD for
SPICE and the three mutants of Fig. 1 to optimize their
modeled structures and to examine their structural integrity
and dynamics. Fig. 2 shows the initial minimized structure of
VCP and ﬁnal minimized structures of 10 ns MD simulations
for VCP, SPICE, VCP2m, VCP3m, and VCP4m. The initial
structures are nearly identical for all proteins because they
are based on structural homology modeling using the crystal
structure of VCP as a template. Simple energy minimization
was applied to the initial structures that corrected for local
unfavorable interactions introduced by the mutations. Fig. 2,
B–F, depicts the intermodular mobility of VCP/SPICE and
their mutants at 10 ns, whereas the structures of the indi-
vidual modules are nearly invariable within the deﬁnition for
the structure of CCPmodules (16). According to CATH classi-
ﬁcation (66) the CCP module belongs in the ‘‘mainly b’’-
class, ‘‘ribbon’’ architecture, and ‘‘complement module’’
topology and homologous superfamily. A more complete
presentation of the integrity of individual modular structures
and the intermodular dynamics during the MD trajectories,
with sampling for every nanosecond, can be found in the
Supplementary Material.
Fig. 3 shows the RMSD time series for each CCP of VCP,
SPICE, VCP2m, VCP3m, and VCP4m. In the 8–10 ns time
frame, the backbone RMSDs for every CCP module have
reached plateau values of stable state for all proteins, with
small RMSD ﬂuctuations depicting the backbone ﬂexibility
for individual CCP modules. Given the backbone RMSD’s
behavior and the objective of our study, it was deemed
unnecessary to continue our MD simulations for longer than
10 ns. Our objective was to perform a comparative study of
the intramodular ﬂexibilities and intermodular mobilities, at
a given time range, for ﬁve homologous proteins differing by
only 2–11 amino acids, rather than a study of the absolute
time evolution of each protein structure. We have used the 10
ns structures to evaluate the titration properties of the proteins
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and the last 2 ns of the MD simulations to quantify the in-
termodular dynamics or mobility and the spatial distribution
of the electrostatic potentials.
Table 1 shows an analysis of intermodular dynamics, using
the tilt, skew, and twist angles for modules CCP1-CCP2,
CCP2-CCP3, andCCP3-CCP4. The use of tilt, skew, and twist
angles is a standard choice in the literature for the evaluation
of the intermodular topology of CCP-module-containing re-
ceptors, regulators, and inhibitors of the complement system
(16,19,20,34–37). Further analysis of intermodular dynamics
was performed using solvent accessibilities. The use of solvent
accessibilities has been a semiquantitative criterion for the com-
parison of intermodular contacts across several complement
RCAs and CRs (16); however, these studies used static crys-
tallographic structures without taking into account inter-
modular mobilities. Fig. 4 shows the difference in SASA of
the sum of the four individual modules minus the SASA of
the whole proteins for VCP, SPICE, VCP2m, VCP3m, and
VCP4m. This ﬁgure depicts the loss or gain of solvent
accessibility by the formation or deformation of intermod-
ular contacts during the MD trajectories. More contacts
are formed at 10 ns than at 0 ns (Fig. 4), which is consistent
with the molecular graphics of Fig. 2 and Supplementary
Material.
Correlated intermodular motions during the MD trajecto-
ries were estimated using covariance analysis. Fig. 5 shows
the cross correlations of CCP module displacements (indeed
oscillations) from their average position during the MD
trajectory for VCP, SPICE, VCP2m, VCP3m, and VCP4m.
There are differences in the motional behavior of module
CCP1 between VCP and SPICE, despite the fact that the
sequence of this module is identical in the two proteins (the
11-amino acid differences between VCP and SPICE are
located in modules CCP2-3). Speciﬁcally, the motion for
pairs (CCP1, CCP2) and (CCP1, CCP3) is anticorrelated in
VCP and correlated in SPICE (Fig. 5). Opposite motional
behavior is observed for pairs (CCP2, CCP4) and (CCP3,
CCP4) between VCP and SPICE, whereas pairs (CCP1,
CCP4) and (CCP2, CCP3) show similar behavior (Fig. 5). It
should be noted that VCP, VCP2m, VCP3m, and VCP4m
demonstrate overall similar motional behavior for CCP1 with
the exception of the motion of (CCP1, CCP2) in VCP4m
which is uncorellated (Fig. 5). The double mutation in CCP2
of VCP2m has a signiﬁcant effect in the relative motion of the
pair (CCP2, CCP3), compared to VCP, and smaller effects
on the remaining pairs, mainly in the magnitude of the cross
correlations. The added, compared to VCP2m, double muta-
tion in CCP1 of VCP4m has a more profound effect in the
relative motions of the pairs (CCP1, CCP2), (CCP2, CCP3),
(CCP2, CCP4), and (CCP3, CCP4). Incorporation of two
mutations in the loop CCP1-2 and one mutation in the loop
CCP3-4 of VCP3m affects mainly the motional behavior of
the pair (CCP2, CCP4) and to a lesser extent that of (CCP3,
CCP4) compared to VCP (Fig. 5).
Fig. 6, A and B, shows the spatial distribution of the
electrostatic potentials of VCP and SPICE for the energy-
minimized initial structures and snapshots from the last 2 ns
of the MD trajectories. The ﬁgure depicts the ﬂuctuations of
the structure and the electrostatic potential at the beginning
and during the end of the MD simulation. A more complete
set of ﬁgures showing the modulation of electrostatic
potentials in 1-ns MD snapshots is given in the Supplemen-
tary Material. The electrostatic potential of VCP consists of
predominantly positive potential at the terminal CCP mod-
ules, CCP1 and CCP4, with a protruding patch of negative
potential in CCP1 and predominantly negative potential at
the CCP2-CCP3 interface (Fig. 6, A and B). The electrostatic
potential of SPICE consists of predominantly positive
potential with patches of small negative potential in CCP1,
CCP4, and the CCP2-CCP3 interface (Fig. 6, C and D).
Some cancellation between positive and negative potentials
occurs at the CCP1-CCP2 and CCP3-CCP4 interfaces (Fig.
6, C andD). The stronger positive potential of SPICE reﬂects
the E-108K/E-120K (CCP2), E-144N/D-178N (CCP3), and
FIGURE 2 Ribbon models for the initial minimized crystal structure of
VCP (A) and the ﬁnal (10 ns) structures from the MD simulations of VCP
(B), SPICE (C), VCP2m (D), VCP3m (E), and VCP4m (F).
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K-214T/K-236Q (CCP4) mutations compared to VCP.
These mutations account for an overall14 charge difference
in favor of SPICE, considering that the Q-77H and H-98Y
mutations compensate for each other if the two histidines
have the same charge state. The difference in the up to 1000-
fold higher activity of SPICE compared to VCP has been
attributed to their differences in the strength and topology of
their electrostatic potentials (21).
FIGURE 3 Backbone heavy atom RMSDs per CCP
module. (A) VCP, (B) SPICE, (C) VCP2m, (D) VCP3m,
and (E) VCP4m. The backbone heavy atoms N, Ca, and
C were used to calculate the RMSDs from the minimized
crystal structures. The stable structures of the last two
nanoseconds were used to calculate intermodular skew,
tilt, and twist angles (Table 1) and electrostatic potentials
(Fig. 6). The MD structures at 10 ns were used to cal-
culate the predicted titration curves and apparent pKa
values (Figs. 8 and 9).
TABLE 1 Intermodular mobility using the tilt, skew, and twist angles for the CCP1-CCP2, CCP2-CCP3, and CCP3-CCP4
modules during the last 2 ns of the MD trajectories
Protein
Tilt angle Skew angle Twist angle
CCP1–CCP2 CCP2–CCP3 CCP3–CCP4 CCP1–CCP2 CCP2–CCP3 CCP3–CCP4 CCP1–CCP2 CCP2–CCP3 CCP3–CCP4
VCP 89.3–10.2/
18.0
97.1–20.0/
115.2
115.7–10.5/
19.3
100.9–9.8/
111.7
138.9–17.4/
118.5
94.9–15.9/
117.0
128–27.5/
125.1
1.75–21.9/
123.0
28.4–14.3/
111.8
SPICE 23.0–7.4/
19.5
62.3–10.7/
115.2
111.0–8.2/
19.8
0.9–23.1/
123.2
162.1–10.6/
114.5
79.1–15.1/
117.5
30.9–12.4/
116.9
67.5–13.8/
122.4
57.3–15.9/
121.5
VCP2m 36.9–12.8/
113.1
91.5–14.9/
125.0
101.1–17.8/
116.3
20.0–18.9/
122.0
111.1–10.4/
113.6
124.1–21.2/
114.3
83.4–31.2/
117.7
22.0–18.0/
118.0
26.3–19.6/
141.4
VCP3m 10.2–6.2/
111.3
75.1–13.7/
112.2
74.4–19.1/
118.0
55.8–35.5/
143.3
144.8–25.1/
131.5
19.3–19.2/
126.5
97.2–24.0/
133.1
4.4–25.6/
121.0
81.6–33.1/
135.9
VCP4m 54.3–9.8/
18.1
116.6–7.9/
110.4
104.3–20.7/
117.1
107.2–9.7/
117.4
141.3–14.0/
114.6
32.1–27.7/
124.8
86.6–11.2/
116.2
31.7–26.3/
126.5
63.9–41.2/
132.5
The mean angle values are shown with the ranges that provide the minimum and maximum angle values.
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Fig. 6, E–J, shows the spatial distribution of the electro-
static potential of VCP2m, VCP3m, and VCP4m for the
energy-minimized initial structures and snapshots from the
last 2 ns of the MD trajectories. The VCP2m mutant was
designed to possess similar spatial distribution of its elec-
trostatic potential as SPICE, with minimum number of muta-
tions using the static x-ray structure of VCP in a previous
study (21). VCP2m has two amino acid mutations, E-108K
and E-120K, in CCP2 as opposed to 11 amino acid mutations
of SPICE in CCP2-4 (Fig. 1). SPICE and VCP2m were
shown to be the most active VCP analogs in inhibiting C3b;
however, their binding proﬁles to C3b were distinct as dem-
onstrated by surface plasmon resonance (21), possibly re-
ﬂecting their dynamic differences (Fig. 6, C–F).
Based on the character of the electrostatic potentials of
VCP, SPICE, and VCP2m we designed the VCP3m analog
with the three-amino acid mutations critically positioned to
nearly eliminate the spatial distribution of the positive elec-
trostatic potential in CCP1-3 (Fig. 6, G and H). The muta-
tions are K-64E, R-66E in the CCP1-2 loop and K-186E in
the CCP3-4 loop. The loop locations were chosen for muta-
tions because the inherent internal ﬂexibility and solvent expo-
sure of the loops is unlikely to affect the tertiary structure of
the CCP modules. Similarly we designed the VCP4m analog
withminimal four-amino acidmutations positioned to enhance
the spatial distribution of the positive electrostatic potential
in CCP1-3 (Fig. 6, I and J). VCP4m has the same mutations
as VCP2m (E-108K and E-120K in CCP2) with the addition
of E-18K and E-32K in CCP1. VCP4m introduces mutations
in the ﬁrst module, which is free of mutations in SPICE.
Each mutation in VCP2m, VCP3m, and VCP4m resulted in
altering the sign of the charge and a change of 62 charge
units. The mutated amino acids had percent SASAs of more
than 25% in the crystal structure of VCP. A solvent-exposed
amino acid can usually be mutated without disturbing the
global structure, which is stabilized mainly by hydrophobic
interactions of the protein core and disulﬁde bridges in the
case of CCP modules. Locally, solvent exposure allows the
mutating amino acid to reorient itself during the MD simu-
lation to form new favorable hydrogen bonds and salt bridges
or local networks of electrostatic interactions in general. We
predict that VCP3m should demonstrate reduced binding and
activity properties and VCP4m should demonstrate enhanced
binding and activity properties.
The electrostatic potentials in Fig. 6 are calculated using
ionic strengths corresponding to 0 mM and 150 mM salt. The
isopotential surfaces are plotted at 61 kBT/e in all cases.
Comparison of the isopotential surfaces using 0 mM and 150
mM salt provides a quantiﬁcation of electrostatic screening
of the protein electrostatic potentials by the salt ions. Plots
at 0 mM salt exaggerate the electrostatic potential proﬁles,
whereas plots at 150 mM salt demonstrate the presence of
variable electrostatic screening by the salt ions, depending on
the local protein structure and charge. The 150mM salt concen-
tration was chosen because it resembles the physiological
ionic strength in serum. The 0 mM salt concentration was
chosen to demonstrate the extreme magnitude of electrostatic
interactions (Coulombic and desolvation effects) of the pro-
teins. It also models in vitro experiments performed in the
absence of salt.
To quantify the differences of the electrostatic potentials
we have calculated ESIs among the ﬁve proteins, using the
minimized structures. ESIs provide a quantitative measure of
the similarity between the magnitudes and distributions of the
electrostatic potentials of two proteins. Fig. 7 shows the
three-dimensional distributions of the ESIs in the form of
similarity distances. In a coarse analysis, the active or pre-
dicted active proteins, VCP, SPICE, VCP2m, and VCP4m,
are clustered together whereas the predicted inactive VCP3m
forms a cluster by itself. In a ﬁner analysis three clusters can
be distinguished: SPICE, VCP2m, and VCP4m are clustered
together, VCP forms a cluster by itself, and VCP3m forms a
FIGURE 4 Calculated difference in the SASA (DSASA) during the MD
trajectory. DSASA is the SASA of the sum of individual CCPs minus the
SASA of the whole protein.
FIGURE 5 Calculated cross correlations of the displacements of pairs
of CCP modules for VCP (black), SPICE (white), VCP2m (horizontal ﬁll),
VCP3m (downward diagonal ﬁll), and VCP4m (upward diagonal ﬁll).
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cluster by itself. The choice of the minimized structures for
the ESI calculation was made to assure a fair comparison
among the ﬁve proteins while they are in a similar overall
conformation.
We have calculated the apparent pKa values for each ioniz-
able amino acid of VCP, SPICE, and their mutants using the
10 ns MD structures. Lists of predicted apparent pKa values
are provided in the Supplementary Material. Fig. 8 shows
examples of predicted titration curves for H-140 of VCP/
SPICE and theirmutants, E-108 andE-120 ofVCP andK-108
and K-120 of SPICE. H-140 shows lower apparent pKa value
from its model pKa value of 6.3 in both VCP and SPICE,
suggesting somehow unfavorable interactions. However,
H-140 shows higher apparent pKa value in VCP2m,
suggesting favorable interactions (Fig. 8 A and Supplemen-
tary Material). E-108 of VCP has a lower apparent pKa value
than a free glutamic acid in solution, suggesting overall favor-
able electrostatic environment (Fig. 8 B and Supplementary
Material). The apparent pKa value for E-120 of VCP is
identical to the pKa of free glutamic acid in solution. K-108
and K-120 of SPICE have apparent pKa values close to those
of free lysines in solution (Fig. 8 B and Supplementary
Material).
We hypothesized that the observed subtle binding differ-
ences between SPICE and VCP2m (21) may be due to the
differences in the apparent pKa values of H-140 (Fig. 8 A).
To further examine this hypothesis we have evaluated the
titration curves ofVCP, SPICE,VCP2m,VCP3m, andVCP4m.
Fig. 9 shows the mean net charge changes as a function of
pH. Fig. 9 B depicts the mean net charge at the vicinity of the
physiological pH, with the mean net charge at pH 7 marked
in the ﬁgure. There is a 1.1 unit charge difference between
SPICE (mean net charge 5.9) and VCP2m (mean net charge
7.0) at pH 7. Examination of the calculated apparent pKa
values (Supplementary Material) suggests that this charge
difference may arise from the apparent pKa differences of
H-140 in SPICE and VCP2m. This hypothesis implicates
H-140, together with the variable modulation of the electro-
static potentials (Fig. 6, C–F) and the distinct modular
motions (Fig. 5) in explaining the subtle differences in binding
to C3b between SPICE and VCP2m. Increase of the positive
mean net charge in the order VCP3m , VCP , VCP2m ;
SPICE , VCP4m correlates well with increase in measured
activities for VCP, SPICE, and VCP2m (21).
FIGURE 6 Isopotential surfaces at 61 kBT/e, com-
paring the ﬂuctuations of the spatial distribution of
electrostatic potentials for the initial minimized crystal
structures and the 8, 9, and 10 ns MD structures. (A and
B) VCP, (C andD) SPICE, (E and F) VCP2m, (G andH)
VCP3m, and (I and J) VCP4m. The electrostatic
potentials were calculated using 0 mM salt concentration
(left columns) and 150 mM salt concentration (right
columns).
FIGURE 7 Three-dimensional plots of ESI distances for VCP, SPICE,
VCP2m, VCP3m, and VCP4m. ESIs were calculated at ionic strengths cor-
responding to 0 mM (A) and 150 mM (B) concentrations. The plot shows the
distinct clustering of the proteins according to the similarity of their electro-
static potentials.
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DISCUSSION
We have performed MD simulations for VCP and a series of
VCP analogs with a minimal number of mutations that have
or are predicted to have variable abilities against binding to
C3b/C4b and inactivation of the complement system. One of
these analogs is SPICE a homologous Orthopoxvirus protein
with higher complement inhibitory activity (21,22). VCP
and SPICE have only 11 amino acid differences in their 244
amino acid sequences. The MD simulations aim to shed light
on the intermodular mobility, variability of the overall shape,
intramodular ﬂexibility, and structural integrity of the
modeled proteins during the MD trajectories of each protein
but also in comparison with each other. A long-standing
question in the ﬁeld of complement research deals with the
linearity, or not, of multi-modular CCP-containing proteins,
such as CR1, CR2, Factor H, MCP, DAF, and VCP
(16,67,68). CR1 consists of 30 CCP modules, CR2 of 15,
Factor H of 20, andMCP, DAF, and VCP of 4 CCP modules.
The CCP modules in these proteins form linear chains con-
nected with short ﬂexible loops. There are several structures
of individual, pairs, triplets, or quartets of modules for these
structures deposited at the PDB (25) from NMR or x-ray
diffraction studies (reviewed in Soares and Barlow (16)).
VCP is a protein with complete four-modular structure (17)
deposited at the PDB and thus a good model system for
computational studies. Another question that often arises
with CCPs is the relation between their mobility and binding
or activity properties. This question could be reformulated as
the relation between the spatial distribution of the physico-
chemical properties of CCPs with binding and activity
properties. Earlier studies have shown that the binding and
activity of various CCPs is modulated by their electrostatic
potentials in the form of long-range interactions (21,23) and/
or by their surface charges in the form of short-range electro-
static interactions (23,58–65). We address the relations among
dynamics (mobility and ﬂexibility), dynamic spatial arrange-
ment of electrostatic properties, and inhibitory activities for
VCP/SPICE and their mutants.
FIGURE 8 Selected titration curves for H-140 of VCP, SPICE, VCP2m,
VCP3m, and VCP4m, E-108, E-120 of VCP, and K-108, K-120 of SPICE.
The MD structures at 10 ns were used to calculate the predicted titration
curves.
FIGURE 9 pH dependence of mean net charge for VCP, SPICE, VCP2m,
VCP3m, and VCP4m. (A) pH range 0–16. (B) The vicinity of physiological
pH in the range of 6–8, with the mean net charge at pH 7 marked. The MD
structures at 10 ns were used to calculate the charges.
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An earlier study has shown a strong correlation between
the strength of the positive electrostatic potential of VCP,
SPICE, VCP2m, and several other analogs with their binding
and activity properties (21). That study used rather simplistic
modeling of the electrostatic potentials based on the solution
of Coulomb’s equation and without the use of partial charges
to account for the electric dipoles within the proteins. It also
used the rigid and unrelaxed crystallographic structure of
VCP for structural homology modeling and for the evalu-
ation of the electrostatic potentials. Here we have used
snapshots from MD trajectories to evaluate the electrostatic
potentials of VCP, SPICE, and VCP2m, for which we have
experimental binding and activity data. We have calculated
the electrostatic potentials using the Poisson-Boltzmann
equation and have included partial charges for the electric
dipoles. The improved calculation reveals a signiﬁcant
difference in the electrostatic character of the CCP4 module
of VCP, which is predominantly positive. This was not
shown in the previous study (21). We also propose that a new
analog with three-amino acid mutations, VCP3m, should
demonstrate diminished binding and activity and a new an-
alog with four-amino acid mutations, VCP4m, should demon-
strate stronger binding and higher activity. The selection of
the mutated amino acids for VCP3m was chosen to signif-
icantly reduce the overall positive electrostatic potential of
VCP, without a major effect on the structural integrity of the
protein. The mutated amino acids are solvent exposed at the
intermodular loops of CCP1-2 and CCP3-4 and are expected
to affect the intermodular dynamics but not the structure of
individual CCP modules. The selection of the mutated amino
acids for VCP4m was chosen to signiﬁcantly enhance the
overall positive electrostatic potential of VCP, without sig-
niﬁcantly disrupting the structure of individual CCPmodules.
Our selection of mutations is based not only on altering the
charge balance but also on altering the spatial distribution of
the electrostatic potential, which takes into account cancel-
lation of positive and negative potentials. In addition, we
have calculated the apparent pKa values for all ionizable
amino acids of VCP, SPICE, VCP2m, VCP3m, and VCP4m
for the ﬁnal MD structures to generate a database of the
amino acids that participate in favorable or unfavorable
Coulombic or desolvation electrostatic interactions.
Our MD simulations have explored the ﬂexibility of the
individual CCP modules of VCP/SPICE and their mutants
(Fig. 2), in the form of the calculated RMSDs (Fig. 3), and
the mobility of CCP modules with respect to each other, in
the form of differences in SASA (Fig. 4), the tilt, skew, and
twist angles (Table 1), and covariance analysis (Fig. 5). We
have evaluated structural integrity by examining the sec-
ondary structure and tertiary fold of individual CCP modules
(Fig. 2 and Supplementary Material). We have used snap-
shots during the MD trajectories to explore the spatiotem-
poral distribution of the electrostatic potentials of VCP and
SPICE (Fig. 6). We show that the spatial distribution of the
electrostatic potentials varies during the MD trajectories with
variable degrees of positive-negative cancellation. Overall,
the active or predicted active proteins have predominantly
positive electrostatic potentials, with increasing strength in
the order VCP3m , VCP , VCP2m ; SPICE , VCP4m.
Small patches of negative potential appear and disappear in
individual CCP modules during the MD trajectories (Fig. 6
and Supplementary Material). Previously, it was proposed
using static structures that the increase of the positive poten-
tial in modules CCP1 and CCP4 and decrease of negative
potential at the interface ofmodules CCP2-CCP3was respon-
sible for increase in binding and activity (21). Here we
propose that the overall positive electrostatic potential of
VCP, SPICE, VCP2m, and VCP4m is responsible for recog-
nition with a region of negative potential in C3b/C4b through
long-range electrostatic interactions, irrespective of the overall
shape of the highly dynamic modular proteins. However, we
expect that a particular topology will be favored for binding
to C3b/C4b through local pairwise electrostatic interactions
in the form of hydrogen bonds and salt bridges or networks
of multiple electrostatic interactions and nonpolar effects, in
addition to long-range electrostatic effects. Our studies are
sufﬁcient to predict the association and activity properties of
VCP, SPICE, VCP2m and correlate well with measured
binding and activity parameters from published experimental
data (21). When experimental data for VCP3m and VCP4m
become available, wewill be able to further reﬁne our hypoth-
eses. We should note that the end result of covering mutated
VCP with a positive electrostatic potential (for active) or a
negative electrostatic potential (for inactive) can be achieved
by a number of different combinations of amino acid muta-
tions. Here we chose the least number of mutations, which
were the least destructive for the structures of individual
CCP modules.
The use of correlations between electrostatic potentials
and the functionality of sets of homologous proteins has been
demonstrated before, most notably in the studies by Wade
and co-workers (53,54,69,70). The correlations suggest that
if two proteins share similar electrostatic potential proﬁles,
they are likely to interact with the same targets. In the case of
similar electrostatic potential proﬁles, variation in the overall
strength of the potentials, locally or globally, can be corre-
lated with variable binding and function for electrostatically
driven processes. This is the case for the group VCP, SPICE,
VCP2m, VCP3m, and VCP4m, as shown in Fig. 7. The
calculated ESIs provide an effective means of differentiation
between predicted active from predicted inactive proteins in
the studied group of VCP/SPICE proteins and their mutants.
Speciﬁcally, the spatial arrangement of the ESIs demon-
strates the presence of three subgroups in the following order
of increasing activity: VCP3m , VCP , (VCP2m, SPICE,
VCP4m) (Fig. 7). In addition to comparisons across proteins
made with ESIs, the cross correlations of modular displace-
ments, discussed below, were useful to quantify correlated
motions within the same protein and to make motion-activity
comparisons across proteins.
Immunophysical Modeling of VCP and SPICE 3115
Biophysical Journal 90(9) 3106–3119
Overall, the effect of mutations in the correlated oscilla-
tory motions of pairs of CCP modules is variable. The
anticorrelation of the motion of modules (CCP1, CCP4) (Fig.
5) can be explained by the repulsive Coulombic interaction
of the overall positive potential of modules CCP1 and CCP4
in all proteins (Fig. 6). The smaller anticorrelation for module
pair (CCP1, CCP4) of VCP3m (Fig. 5) may be due to a more
balanced potential in CCP1 compared to the rest of the pro-
teins (Fig. 6). The magnitude of the anticorrelated motion of
the module pair (CCP1, CCP4) differentiates, to a certain
extent, the predicted active proteins, VCP, SPICE, VCP2m,
and VCP4m (cross correlation of 0.91 to 0.99) from the
predicted inactive protein, VCP3m (cross correlation of
0.66; Fig. 5). Similar direct arguments for potential/motion
correlation cannot be made when the middle modules are in-
volved because of more complex interactions, more balanced
charge, and dynamic canceling of positive and negative elec-
trostatic potentials depending on their spatial distribution.
Overall, SPICE demonstrates very distinct behavior com-
pared to VCP, VCP2m, VCP3m, and VCP4m, reﬂecting the
combined effect of the 11 mutations in the intermodular
dynamics. A more detailed principal component analysis
using individual (x, y, z) coordinate displacements, as op-
posed to the vector, r(x, y, z), for modules and for Ca-atoms
will be the subject of future analysis.
Based on our pKa calculations and the titration curves of
the proteins, we propose that the subtle differences in
binding of SPICE and VCP2m to C3b (21) may be attributed
to differences in the protonation state of H-140 (Figs. 8 and
9). The local environment of H-140 is inﬂuenced by dif-
ferences in the intermodular mobility of SPICE and VCP2m
(Fig. 6). Our study is an example of the use of electrostatic
potentials to predict activities for VCP/SPICE and their
mutants.
In essence, our studies suggest a two-step model for the
interaction of VCP/SPICE and their mutants with their target
complement proteins C3b/C4b. The two steps are recogni-
tion (formation of an encounter complex) and binding (forma-
tion of the ﬁnal complex). The global electrostatic potentials
model the recognition step. Detail modeling of the binding
step is not possible at the time because of the absence of
structural information of the formed complexes and their
binding sites. Our two-step model is in the same line of
thought as our earlier study for CR2-C3d association (23). In
the CR2-C3d study we were able to be more speciﬁc on the
mechanism of association because we had available and used
the three-dimensional structures of free CR2 (71), free C3d
(61), and CR2-C3d complex (60), where CR2 contained only
the ﬁrst two CCP modules, which are responsible for
association with C3d. The ﬁrst step involved recognition
through long-range electrostatic interactions; and the second
step involved the actual binding through electrostatic inter-
actions (long-range and short-range in the form of hydrogen
bonds, salt bridges, and desolvation), hydrophobic, and van
der Waals interactions, in addition to entropic effects
involving the solvent exclusion and local structural rear-
rangements at the binding sites (23). Based on the electro-
static potentials of a predominantly positively charged CR2
and a predominantly negatively charged C3d, we were able
to explain the binding abilities for C3d mutants at and away
from the association interface (23). A subsequent exper-
imental study has produced additional mutational analysis
on the CR2 component of the CR2-C3d complex with the
overall ﬁndings in agreement with CR2-C3d association
driven by electrostatics, although the authors focus their
analysis on short-range effects (59).
Some of our theoretical predictions for the involvement of
individual amino acids in function have been previously
addressed by experimental studies. According to our model,
the recognition step depends on long-range electrostatic
properties. The kinetic and binding variations observed for a
number of VCP mutants in a previous study using surface
plasmon resonance (21) are due to combined long- and short-
range interactions. Several of our mutated VCP acidic amino
acids to basic in VCP2m and VCP4m are indeed basic amino
acids in the homologous CCP modules of CR1 (the C3b/C4b
binding Site 2, modules CCP8–10 and CCP15–17) (16).
Also, homologous amino acids in MCP have variable charge.
Speciﬁcally, the VCP mutations (homologous residues for
CR1, MCP, respectively, in parentheses) are E-18K (K-912,
E-11), E-32K (K-929, D-27), K-64E (K-959, R-62), R-66E
(K-961, -), E-108K (I-1005, E-108), E-120K (K-1016,
K-119), K-186E (K-1095, K-193). Structure-guided muta-
genesis studies of the C3b/C4b binding site 2 of CR1
(modules CCP15–17 for which there are structures) have
shown that the corresponding basic amino acids for VCP
positions 18, 64, 66, and 120 (K-912, K-959, K-961, and K-
1016) when mutated to neutral or negative amino acids (in
single or multiple mutations) resulted to reduction or
abrogation of activity (discussed collectively with other
similar mutations in Smith et al. (36) and Krych-Goldberg
et al. (72)). The authors of these studies treat the mutations of
basic to neutral or acidic amino acids in view of mainly local
interactions; however, in some instances they were able to
separate global (or nonspeciﬁc according to Krych-Goldberg
et al. (72)) from local electrostatic effects. Mutations of
charged amino acids in the CCP2–4 modules of MCP,
including corresponding VCP positions 120 and 186 (K-119
and K-193 in MCP), also demonstrate inﬂuence in C3b/C4b
binding and/or cofactor activity for C3b and C4b degradation
(62). Also, based on mutation of one tyrosine of the Y-97,
Y-98 pair in MCP, it has been previously discussed that these
tyrosines may be important for C4b cofactor activity (22,62).
SPICE has a similar pair of tyrosines, from which Y-97
demonstrates unusually high pKa value (Supplementary
Material) due to local electrostatic interactions. Our predicted
apparent pKa values (Supplementary Material) depict a
number of ionizable amino acids that participate in networks
of electrostatic interactions but have not been previously
discussed in the literature. Overall, our study combines a
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macroscopic approach for the effect of the electrostatic po-
tentials in recognition and an amino acid-speciﬁc approach, in
the form of pKa values, for global or local association effects.
Our data suggest that intermodular dynamics are an
integral part of the function of VCP/SPICE and their mu-
tants. Mutations not only at intermodular loops but also at
individual CCPs result in differences in intermodular dy-
namics (Figs. 2, 4, 5, and 6, and Supplementary Material).
For our detailed analysis of intermodular dynamics, we have
used the last 2 ns of the MD trajectories, during which the
RMSDs per module have reached stable states (Fig. 3). The
variability of the intermodular angles (Table 1) suggests that
an exact intermodular topology may not be necessary for
recognition and that the binding sites may be dynamic in
nature. Variability of intermodular angles has been observed
before in comparative studies of x-ray and NMR structures
of RCAs and CRs made of CCPs (16,35).
NMR structural and relaxation data have addressed the
intermodular mobility in the central region of VCP, modules
CCP2-3 (19), and the C-terminal half of VCP, modules
CCP3-4 (20). NOE data and the determined time-averaged
structures based on simulated annealing and NMR restraints
have shown that modules CCP3 and CCP4 share an exten-
sive interface, whereas modules CCP2 and CCP3 do not
(19,20). However, it should be noted that the two central
CCP modules differ signiﬁcantly in the NMR structure of
VCP(CCP2-3) (19) and the crystal structure of VCP(CCP1-
4) (17) and that the crystal structure is not compatible with
the observed NOE data (19). These differences may be due
to the shorter length of VCP(CCP2-3), crystal packing effects,
or sample conditions. In addition, 15N relaxation NMR data
for the central CCP2-3 modules were consistent with a large
number of intermodular orientations and the presence of
interconversion among them (19). The NMR relaxation data
also suggest that many of the intermodular orientations are
kinked. Other studies of VCP(CCP2-3) have suggested that
CCP2-CCP3 are in an elongated arrangement without sharing
an extensive intermodular interface, which would have been
promoted by kinking (73). This proposal was made using
analytical ultracentrifugation measurements and unfolding
studies monitored by NMR, differential scanning calorimetry,
circular dichroism, and intrinsic tryptophan ﬂuorescence.
Care should be taken when comparing data from different
biophysical methods collected using different sample con-
ditions, such as concentration, pH, ionic strength, buffer com-
position, temperature, etc. In the case of VCP(CCP2-3) the
differences in the CCP2-3 average orientation between the
NMR relaxation and ultracentrifugation data were previously
attributed to differences in temperature (19). Overall, our con-
clusions on intermodular mobility of VCP, based on the MD
data, are in agreement with the NMR relaxation data.
Another type of ‘‘mobility’’ of the binding surfaces has
been proposed earlier within individual CCP modules of
CR1 and MCP using NMR relaxation data (74). This study
suggested mobile b-strands (and surfaces) in CCPs, which is
addressed within the deﬁnition of ﬂexibility in our study. Our
observation of dynamic binding properties involving mobile
CCP modules is an extension of the previous ﬁndings in
O’Leary et al. (74).
Our data contribute to our understanding of the basic
immunophysical properties for CCP modules in VCP and
SPICE. The immunophysical properties are the intramodular
and intermodular dynamics and the type and spatial distri-
bution of the electrostatic potentials, which are modulated by
the intermodular dynamics. Our data also demonstrate the
power of dynamic and electrostatic modeling to design VCP/
SPICE analogs with higher or lower activities, which can be
used as the basis to design agonists or antagonists of the
native viral proteins. Also, this type of modeling is useful to
design inhibitors of unregulated complement activation in
pathological situations, such as autoimmune diseases, ische-
mia reperfusion injury, trauma, cardiopulmonary bypass sur-
gery, and others.
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